The 17 members of a federal vaccine advisory committee, who were ousted last week, argued their abrupt dismissal has "left the U.S. vaccine program critically weakened." The group, speaking ...

CHARLOTTE — Whitney Hamilton says her 4-year-old son, Elijah, is always happy, but his life dramatically changed in February ...

The incidence of RSV across 5 respiratory virus seasons was substantial among adult patients with high-risk underlying conditions.

Dr. Lbiati's appointment signals a new chapter for Hepion-one focused on strategic renewal, value creation, and diagnostic ...

Cleveland health officials are warning residents after a 250% spike in COVID-19 viral levels was found in city wastewater.

Cleveland Department of Public Health officials are warning of a “strong likelihood of increased community spread in the ...

The Food and Drug Administration (FDA) expanded the approval of Moderna’s RSV vaccine late Thursday to include individuals 18-59 years of age who are at increased risk for severe illness from ...

The FDA has approved Enflonsia (clesrovimab-cfor) for the prevention of RSV lower respiratory tract disease in neonates and ...

In a major boost for infant health, the U.S. Food and Drug Administration (FDA) has approved ENFLONSIA (clesrovimab-cfor) , a ...

A newly approved shot could soon help protect babies from respiratory syncytial virus (RSV), the top cause of hospitalization ...

Scientists and analysts express concern that the newly appointed members—which include known anti-vaxxers—could relitigate ...

The Food and Drug Administration has approved a new drug from Merck designed to protect infants from respiratory syncytial virus, or RSV, a common but potentially serious seasonal illness.